Emmes, a global, full-service Clinical Research Organisation, has acquired Europe-based Neox sro, it was reported on Wednesday.

Neox sro will add more than 150 employees who support biotechnology, pharmaceutical, and medical device companies. This transaction will bring the total number of employees at Emmes to more than 1,000 globally.

Based in Prague, Neox has operations primarily in central and eastern Europe, with a direct presence in the Czech Republic, Bulgaria, Germany, Hungary, Poland, Romania, Slovakia and Slovenia. The company operates in another 11 European countries, including a recently established entity in the United Kingdom.

Dr Christine Dingivan, Emmes chief executive officer, said, 'This is an important and exciting step for Emmes, demonstrating significant progress on our strategic plans to grow our biopharmaceutical business. Neox adds a sizable, well-established biopharmaceutical research services business to Emmes and significantly expands our international presence.'